Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Por Meier, J J, Gallwitz, B, Schmidt, W E, Mügge, A, Nauck, M A
Publicado em 2004

Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide.

Por Schmidt, W E, Kratzin, H, Eckart, K, Drevs, D, Mundkowski, G, Clemens, A, Katsoulis, S, Schäfer, H, Gallwitz, B, Creutzfeldt, W
Publicado em 1991

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Por Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., ’t Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.
Publicado no Diabetologia (2007)

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Por Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.
Publicado em 2007

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Por Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.
Publicado no Diabetologia (2009)